Martingale Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,525
| Closed | -$309K | – | 767 |
|
|
2024
Q3 | $309K | Hold |
12,525
| – | – | 0.01% | 707 |
|
|
2024
Q2 | $317K | Buy |
12,525
+1
| +0% | +$25 | 0.01% | 685 |
|
|
2024
Q1 | $318K | Hold |
12,524
| – | – | 0.01% | 700 |
|
|
2023
Q4 | $284K | Sell |
12,524
-4
| -0% | -$91 | 0.01% | 712 |
|
|
2023
Q3 | $233K | Sell |
12,528
-1,170
| -9% | -$21.8K | ﹤0.01% | 725 |
|
|
2023
Q2 | $356K | Buy |
13,698
+1,776
| +15% | +$46.1K | 0.01% | 672 |
|
|
2023
Q1 | $342K | Buy |
+11,922
| New | +$342K | 0.01% | 688 |
|
|
2014
Q3 | – | Sell |
-8,155
| Closed | -$378K | – | 848 |
|
|
2014
Q2 | $378K | Sell |
8,155
-8,352
| -51% | -$387K | 0.01% | 743 |
|
|
2014
Q1 | $679K | Buy |
16,507
+1
| +0% | +$41 | 0.02% | 612 |
|
|
2013
Q4 | $630K | Buy |
16,506
+2,202
| +15% | +$84K | 0.02% | 699 |
|
|
2013
Q3 | $342K | Buy |
+14,304
| New | +$342K | 0.01% | 852 |
|